YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Vancouver, British Columbia--(Newsfile Corp. - September 29, 2026) - Masivo Silver Corp. (TSXV: MASS) (OTC Pink: GNYPF) ("Masivo" or the "Company") is pleased to report encouraging analytical results from Drill Hole CC-26-001, the first dr…
Image source: The Motley Fool. DATE Tuesday, Aug. 11, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Investor Relations - Barbara Russo Chief Executive Officer and Co-Founder - Kevin Knopp Chief Financial Officer - Joe Griffith Full Conference Cal…
908 Devices Inc. Q2 2026 Earnings Call Summary - Moby Strategic Execution and Market Dynamics Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Ta…
Key Points Interested in 908 Devices Inc.? Here are five stocks we like better. Second-quarter revenue rose 23% to $16.1 million, driven by U.S. state and local government demand, FTIR shipments and the NIRLab acquisition. The company ship…
PROCEPT BioRobotics Corporation (PRCT) came out with a quarterly loss of $0.47 per share versus the Zacks Consensus Estimate of a loss of $0.46. This compares to a loss of $0.35 per share a year ago. These figures are adjusted for non-recu…
Company Logo The global mobile mass spectrometers market is set to grow from USD 1.68 billion in 2026 to USD 2.87 billion by 2031, at a CAGR of 11.3%. This significant growth is driven by the demand for real-time, on-site chemical analysis…
Image source: The Motley Fool. DATE Wednesday, May 6, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Kevin Knopp Chief Financial Officer — Joseph Griffith Full Conference Call Transcript Kevin Knopp: Thanks, Barbara. Good…
908 Devices Inc. (MASS) came out with a quarterly loss of $0.15 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.22 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago,…
BURLINGTON, Mass., April 21, 2026--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces the appointment of Kola Otitoju as its Chief Business & Strategy Officer, a n…
908 Devices logo Key Points Transformation and 2025 results: 908 Devices shifted away from desktop products to focus on field detection and reported 18% YoY growth for 2025, positive adjusted EBITDA in Q4, $113 million in cash, and a 57% a…
NEW YORK, NY / ACCESS Newswire / March 18, 2026 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day March Small-Cap Virtual Investor Conference taking place Wedne…
908 Devices logo Key Points $17.4 million in Q4 revenue from continuing operations, up 21% YoY, driven by strong XplorIR demand and the new VipIR (>40 units shipped, >$3M revenue); the company shipped 224 devices in the quarter and had an…
Image source: The Motley Fool. Date Tuesday, March 3, 2026 at 8:30 a.m. ET Call participants Chief Executive Officer and Co-Founder — Kevin J. Knopp Chief Financial Officer — Joseph H. Griffith Need a quote from a Motley Fool analyst? Emai…
Aristotle Funds, an investment advisor, released its “Growth Equity Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. U.S. equity markets reached new all-time highs in Q4 2025, with the S&P 500 Index r…
Image source: The Motley Fool. DATE Monday, November 10, 2025 at 8:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer and Co-Founder — Kevin Knopp Chief Financial Officer — Joseph H. Griffith Need a quote from a Motley Fool analyst? Emai…
* 908 Devices press release [https://seekingalpha.com/pr/20300027-908-devices-reports-third-quarter-2025-financial-results-and-reiterates-2025-revenue-outlook] (MASS [https://seekingalpha.com/symbol/MASS]): Q3 GAAP EPS of -$0.41 misses by…
Sight Sciences, Inc. (SGHT) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to a loss of $0.22 per share a year ago. These figures are adjusted for non-recurring items…
Penumbra (PEN) came out with quarterly earnings of $0.97 per share, beating the Zacks Consensus Estimate of $0.9 per share. This compares to earnings of $0.85 per share a year ago. These figures are adjusted for non-recurring items. This q…
Wall Street expects a year-over-year increase in earnings on lower revenues when 908 Devices Inc. (MASS) reports results for the quarter ended September 2025. While this widely-known consensus outlook is important in gauging the company's…
908 Devices Inc. MASS shares ended the last trading session 7% higher at $7.3. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 13.3% gain over th…
Cathie Wood’s ARK ETFs have made notable moves in the market on Tuesday, 12 August 2025, with a series of buys and sells that signal the investment firm’s strategic adjustments. The most significant transaction of the day involved the sale…
Cathie Wood’s ARK ETFs have published their daily trades for Monday, August 4th, 2025, reflecting a mix of strategic buys and sells across various sectors. Leading the day’s activity was a significant sell-off of Roblox Corp (PRE-REINCORPO…
Cathie Wood’s ARK ETFs have made significant moves in the stock market on Friday, August 1, 2025, with a particular focus on tech and biotech companies. Leading the trades was a massive purchase of Coinbase Global Inc (NASDAQ:COIN) shares,…
Cathie Wood’s ARK ETFs disclosed their daily trades for Wednesday, July 9th, 2025, with a significant focus on the tech and healthcare sectors. In the largest transaction of the day, ARK increased its position in Tempus AI Inc (NYSE:TEM),…
In the ever-evolving landscape of exchange-traded funds, Cathie Wood’s ARK ETFs remain a focal point for investors seeking exposure to disruptive innovation. The daily trade report for Tuesday, 08 July 2025, showcases ARK’s latest strategi…
Cathie Wood’s ARK ETF published their daily trades for Monday, July 7th, 2025, revealing a continued interest in genomics with a significant investment in Beam Therapeutics Inc (NASDAQ:BEAM), while reducing positions in several other compa…
Cathie Wood’s ARK ETFs disclosed their daily trades for Thursday, 3rd July 2025, with a mix of buys and sells across various sectors. The most significant trade of the day involved the sale of KOMATSU LTD (TYO:6301) shares, with ARKX (NYSE…
Cathie Wood’s ARK ETFs have reported their daily trades for Wednesday, July 2nd, 2025, showcasing a mix of aggressive buys and strategic sells that may signal the firm’s shifting investment focus. The largest transaction of the day involve…
Cathie Wood’s ARK ETFs have made their latest round of daily trades on Tuesday, 01 July 2025, with significant activity across a variety of sectors. In a notable move, ARK has increased its holdings in Tesla Inc (NASDAQ:TSLA) with a substa…
BOSTON - 908 Devices Inc. (NASDAQ:MASS), a company specializing in handheld devices for chemical analysis, announced Monday the appointment of Christopher D. Brown, PhD, to its Board of Directors, effective immediately. Brown, a co-founder…
Key Points The specialty device maker announced it had delivered its devices to an important European customer. The Romanian Customs Authority has deployed 27 MX908 detection devices. 10 stocks we like better than 908 Devices › A deal agre…
Although the recent 90-day pause in the U.S.-China trade conflict is cheering the market, it does not provide complete relief. The market will remain highly volatile without a comprehensive trade agreement and greater clarity on broader ec…
We recently published a list of Why These 15 Healthcare Stocks Are Surging in 2025. In this article, we are going to take a look at where 908 Devices Inc. (NASDAQ:MASS) stands against other healthcare stocks that are surging in 2025. After…
Participants Jacob Johnson; Vice President-Investor Relations; Repligen Corp. Olivier Loeillot; President, Chief Executive Officer, Director; Repligen Corp. Jason Garland; Chief Financial Officer; Repligen Corp. Rachel Vatnsdal; Analyst; J…
The major averages were fractionally higher near noon, adding slightly to yesterday’s gains as investors reacted to fresh headlines on U.S.-China trade tensions and a new round of corporate earnings. Markets are attempting to stabilize aft…
For Immediate Release Chicago, IL – April 8, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial mar…